Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis.
Kool R, Dragomir A, Kulkarni GS, Marcq G, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Kassouf W. Kool R, et al. Eur Urol Oncol. 2024 Feb 6:S2588-9311(24)00040-3. doi: 10.1016/j.euo.2024.01.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38326142
Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy.
Marcq G, Evaristo G, Kool R, Shinde-Jadhav S, Skowronski R, Mansure JJ, Souhami L, Cury F, Brimo F, Kassouf W. Marcq G, et al. Among authors: kool r. Eur Urol Open Sci. 2022 Jul 13;43:14-21. doi: 10.1016/j.euros.2022.06.009. eCollection 2022 Sep. Eur Urol Open Sci. 2022. PMID: 36353066 Free PMC article.
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.
Bhindi B, Kool R, Kulkarni GS, Siemens DR, Aprikian AG, Breau RH, Brimo F, Fairey A, French C, Hanna N, Izawa JI, Lacombe L, McPherson V, Rendon RA, Shayegan B, So AI, Zlotta AR, Black PC, Kassouf W. Bhindi B, et al. Among authors: kool r. Can Urol Assoc J. 2021 Aug;15(8):E424-E460. doi: 10.5489/cuaj.7367. Can Urol Assoc J. 2021. PMID: 33938798 Free PMC article. No abstract available.
Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications.
Séguier D, Puech P, Kool R, Dernis L, Gabert H, Kassouf W, Villers A, Marcq G. Séguier D, et al. Among authors: kool r. Ther Adv Urol. 2021 Aug 25;13:17562872211039583. doi: 10.1177/17562872211039583. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 34457041 Free PMC article. Review.
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.
Bhindi B, Kool R, Kulkarni GS, Siemens DR, Aprikian AG, Breau RH, Brimo F, Fairey A, French C, Hanna N, Izawa JI, Lacombe L, McPherson V, Rendon RA, Shayegan B, So AI, Zlotta AR, Black PC, Kassouf W. Bhindi B, et al. Among authors: kool r. Can Urol Assoc J. 2021 Aug;15(8):230-239. doi: 10.5489/cuaj.7487. Can Urol Assoc J. 2021. PMID: 35099374 Free PMC article. No abstract available.
102 results